Literature DB >> 23377383

New design of the Amplatzer membranous VSD occluder: a step forward?

Kiran Mallula1, Najma Patel, Zahid Amin.   

Abstract

Closure of perimembranous ventricular septal defects (PmVSDs) [4] with the original Amplatzer membranous VSD occluder (mVSD1) has been associated with an increased risk of complications, the most notable of which has been complete heart block. This has led to the introduction of a new device to close PmVSDs. The authors describe their experience with the new Amplatzer membranous VSD occluder (mVSD2) in two patients and critique the new device design and delivery system, comparing it with the mVSD1 occluder. Two patients underwent attempted closure of PmVSDs with the new mVSD2 device. One patient had successful closure of the defect with no residual shunt and no evidence of heart block at follow-up evaluation. Trace to mild aortic insufficiency was observed at the time of closure and at the last follow-up visit. The rhythm remained sinus. In the second patient, the device was placed but removed before release because of inability to orient the device in optimal position. Percutaneous closure of PmVSD is feasible with the new mVSD2 occluder. The change in the design may reduce the incidence of complete heart block. It remains to be seen whether the device will be suitable for smaller patients.

Entities:  

Mesh:

Year:  2013        PMID: 23377383     DOI: 10.1007/s00246-013-0636-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device.

Authors:  John L Bass; Daniel Gruenstein
Journal:  Catheter Cardiovasc Interv       Date:  2011-12-12       Impact factor: 2.692

2.  Transcatheter closure of perimembranous VSD: symmetric and asymmetric occluders.

Authors:  Victor Lucas
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-01       Impact factor: 2.692

Review 3.  Percutaneous closure of ventricular septal defects. State of the art.

Authors:  Gianfranco Butera; Massimo Chessa; Mario Carminati
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2007-01       Impact factor: 2.160

4.  Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.

Authors:  Yun-Ching Fu; John Bass; Zahid Amin; Wolfgang Radtke; John P Cheatham; William E Hellenbrand; David Balzer; Qi-Ling Cao; Ziyad M Hijazi
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

5.  Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study.

Authors:  J Masura; W Gao; P Gavora; K Sun; A Q Zhou; S Jiang; L Ting-Liang; Y Wang
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

6.  Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.

Authors:  Daniel Velasco-Sanchez; Apostolos Tzikas; Reda Ibrahim; Joaquim Miró
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-15       Impact factor: 2.692

7.  Transcatheter closure of congenital ventricular septal defects: results of the European Registry.

Authors:  Mario Carminati; Gianfranco Butera; Massimo Chessa; Joseph De Giovanni; Gunter Fisher; Marc Gewillig; Mathias Peuster; Jean Francois Piechaud; Giuseppe Santoro; Horst Sievert; Isabella Spadoni; Kevin Walsh
Journal:  Eur Heart J       Date:  2007-08-07       Impact factor: 29.983

8.  Complete heart block associated with device closure of perimembranous ventricular septal defects.

Authors:  Dragos Predescu; Rajiv R Chaturvedi; Mark K Friedberg; Lee N Benson; Akira Ozawa; Kyong-Jin Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-06       Impact factor: 5.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.